PHASE I/II TRIAL OF PSC 833 AND OTHERS IN NONHODGKINS LYMPHOMA
PHASE I/II TRIAL OF PSC 833 AND OTHERS IN NONHODGKINS LYMPHOMA
批准号:
6219314
负责人:
SANDRA J. HORNING
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
关键词:
P glycoprotein clinical research clinical trial phase I combination cancer therapy combination chemotherapy cyclophosphamide cyclosporines drug interactions drug screening /evaluation etoposide gene expression human subject human therapy evaluation mitoxantrone multidrug resistance nonHodgkin's lymphoma prednisone vincristine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Expression of the mdr1 gene may be an important cause of chemotherapy failure in patients with Non-Hodgkin's Lymphoma. ONCEP (Vincristine (0), Novantrome (N), Cyclophophamide (C), Etoposide (E), and Prednisone (P)) chemotherapy contains three MDR (Multi-drug resistance) -related agents (ON, E) and was designed for studies of MDR modulation. PC 833 is a non-immunosuppressive cyclosporine with greater in vitro MDR modulating activity that Cyclosporin A. ONCEP-PSC chemotherapy is well tolerated and has significant activity in patients with recurrent or refractory NHL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autografting for Lymphoma
-
批准号:8260362
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2011
-
负责人:SANDRA J. HORNING
-
依托单位:
Autografting for Lymphoma
-
批准号:7212897
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2007
-
负责人:SANDRA J. HORNING
-
依托单位:
EFFICACY OF ANTI-CD20 ANTIBODY IN LYMPHOCYTE PREDOMINANT HODGKIN'S DISEASE
-
批准号:7605162
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2007
-
负责人:SANDRA J. HORNING
-
依托单位:
CLINICAL TRIAL: EVALUATE THE EFFICACY OF ANTI-CD20 ANTIBODY IN LYMPHOCYTE PREDOM
-
批准号:7717845
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2007
-
负责人:SANDRA J. HORNING
-
依托单位:
EFFICACY OF ANTI-CD20 ANTIBODY IN LYMPHOCYTE PREDOMINANT HODGKIN'S DISEASE
-
批准号:7375191
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2005
-
负责人:SANDRA J. HORNING
-
依托单位:
EFFICACY OF ANTI-CD20 ANTIBODY IN LYMPHOCYTE PREDOMINANT HODGKIN'S DISEASE
-
批准号:7202019
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2004
-
负责人:SANDRA J. HORNING
-
依托单位:
TREATMENT OF PATIENTS WITH LARGE B-CELL LYMPHOMA
-
批准号:7202057
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2004
-
负责人:SANDRA J. HORNING
-
依托单位:
A Phase II Study: Rituximab, rhuMAb VEGF (bevacizumab)
-
批准号:6980946
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2003
-
负责人:SANDRA J. HORNING
-
依托单位:
Evaluate the Efficacy of Anti-CD20 Antibody in Hodgkin's
-
批准号:6980890
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2003
-
负责人:SANDRA J. HORNING
-
依托单位:
AUTOGRAFTING FOR LYMPHOMA
-
批准号:6395686
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2000
-
负责人:SANDRA J. HORNING
-
依托单位:
PHASE II STUDY OF IODINE 131 ANTI BI ANTIBODY FOR NON HODGKINS LYMPHOMA
-
批准号:6486028
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:SANDRA J. HORNING
-
依托单位:
PHASE II STUDY OF IODINE 131 ANTI BI ANTIBODY FOR NON HODGKINS LYMPHOMA
-
批准号:6305118
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:SANDRA J. HORNING
-
依托单位:
AUTOGRAFTING FOR LYMPHOMA
-
批准号:6102532
-
项目类别:
-
资助金额:$22.14万
-
财政年份:1999
-
负责人:SANDRA J. HORNING
-
依托单位:
PHASE II STUDY OF IODINE 131 ANTI BI ANTIBODY FOR NON HODGKINS LYMPHOMA
-
批准号:6264331
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:SANDRA J. HORNING
-
依托单位:
LUTETIUM TEXAPHYRIN (PCT-0123) INJECTION IN PHOTODYNAMIC TREATMENT
-
批准号:6115043
-
项目类别:
-
资助金额:$4.03万
-
财政年份:1998
-
负责人:SANDRA J. HORNING
-
依托单位:
PHASE I/II TRIAL OF PSC 833 AND OTHERS IN NONHODGKINS LYMPHOMA
-
批准号:6115021
-
项目类别:
-
资助金额:$4.03万
-
财政年份:1998
-
负责人:SANDRA J. HORNING
-
依托单位:
AUTOGRAFTING FOR LYMPHOMA
-
批准号:6269404
-
项目类别:
-
资助金额:$21.71万
-
财政年份:1998
-
负责人:SANDRA J. HORNING
-
依托单位:
LUTETIUM TEXAPHYRIN (PCT-0123) INJECTION IN PHOTODYNAMIC TREATMENT
-
批准号:6276278
-
项目类别:
-
资助金额:$4.03万
-
财政年份:1997
-
负责人:SANDRA J. HORNING
-
依托单位:
AUTOGRAFTING FOR LYMPHOMA
-
批准号:6237048
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1997
-
负责人:SANDRA J. HORNING
-
依托单位:
PHASE I/II TRIAL OF PSC 833 AND OTHERS IN NONHODGKINS LYMPHOMA
-
批准号:6246162
-
项目类别:
-
资助金额:$3.61万
-
财政年份:1997
-
负责人:SANDRA J. HORNING
-
依托单位:
海外基金